Back to news
BUSINESSThe Dales Report

TDR Reviews a Canadian Medical Cannabis Model for U.S. Operators

The Dales Report interviewed Avicanna CEO Aras Azadian about standardized noncombustible products, pharmacist-led patient support, insurance coverage and clinic integration in Canada. For Oklahoma operators, the discussion highlights product-development and care-model opportunities that may become more important as federal rescheduling separates medical cannabis from conventional retail.

Share this update

FacebookXLinkedInEmail

#national#rescheduling#research#compliance

Read the original source

Leafy summaries provide industry context. Confirm details with The Dales Report.

Open source

Continue reading

Related industry updates